Aliya Gulamhusein

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

Sun‐Gou Ji, Brian D. Juran, Sören Mucha et al. · Nature Genetics · 2016 · 382 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

Michael Trauner, Aliya Gulamhusein, Bilal Hameed et al. · Hepatology · 2019 · 259 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Carla Fiorella Murillo Perez, Maren H. Harms, Keith D. Lindor et al. · The American Journal of Gastroenterology · 2020 · 171 citations · Full text

Medicine, Internal Medicine, Hepatology +16

Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver

Tallulah Andrews, Diana Nakib, Cátia T. Perciani et al. · Journal of Hepatology · 2024 · 159 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD

Aliya Gulamhusein, John E. Eaton, James H. Tabibian et al. · The American Journal of Gastroenterology · 2016 · 117 citations

Medicine, Oncology, Pathology +17